Heparin-induced Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Heparin-induced Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia [Phase 2]
A Phase 2 study evaluating VLX-1005 versus placebo for suspected heparin-induced thrombocytopenia was terminated.
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban [Phase 3]
Phase 3 trial comparing danaparoid to argatroban in heparin-induced thrombocytopenia was terminated.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT) [Phase 2]
Phase 2 trial evaluating apixaban for efficacy and safety in heparin-induced thrombocytopenia (HIT); study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT) [Phase 3]
A multi-center single-arm Phase 3 trial evaluating the effectiveness of varying warfarin therapy duration in patients with heparin-induced t…
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Rapid Diagnosis of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients
The study evaluating rapid diagnosis of heparin-induced thrombocytopenia in surgical critically ill patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia [Phase 3]
A Phase 3 clinical trial evaluating rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia has been terminated…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II [Phase 2]
Phase 2 study evaluating argatroban for management of heparin-induced thrombocytopenia type II; results posted.
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study
A retrospective analysis assessing the incidence and outcomes of heparin-induced thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Heparin-Induced Thrombocytopenia Score Card Study [Phase 1]
A Phase 1 clinical trial update reports completion of the Heparin-Induced Thrombocytopenia Score Card study sponsored by McMaster University…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT) [Phase 2]
Phase 2 clinical trial evaluating fondaparinux for treating heparin-induced thrombocytopenia has been terminated with results posted in 2013…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery
A completed clinical trial update evaluated the risk of developing antibodies to heparin-PF4 after heart surgery. This immune response is as…
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome [Phase 4]
Phase 4 clinical trial comparing Argatroban intravenous versus Desirudin subcutaneous in suspected heparin-induced thrombocytopenia; the stu…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients
This completed clinical trial evaluated management of heparin-induced thrombocytopenia in liver transplant recipients.
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Argatroban Versus Lepirudin in Critically Ill Patients [Phase 4]
A Phase 4 trial comparing Argatroban to Lepirudin in critically ill patients with heparin-induced thrombocytopenia has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion [Phase 4]
Phase 4 trial assessed the relevance of heparin/platelet factor 4 antibodies on vein graft patency after coronary bypass surgery and explore…
-
CLINICAL_TRIALS trial_result · 2011-12-06Clinical Trial Update: Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis [Phase 1]
Phase 1 clinical trial assessing dose finding and pharmacokinetics of fondaparinux in pediatric patients with thrombosis, including cases of…
-
CLINICAL_TRIALS trial_result · 2011-11-10Clinical Trial Update: Angiomax in Patients With HIT/HITTS Type II Undergoing CPB [Phase 3]
Phase 3 trial assessing Angiomax (bivalirudin) in patients with heparin-induced thrombocytopenia undergoing cardiopulmonary bypass has compl…
-
CLINICAL_TRIALS trial_result · 2011-09-16Clinical Trial Update: Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) [Phase 3]
Phase 3 trial update evaluating bivalirudin as anticoagulant therapy during percutaneous coronary intervention in patients with heparin-indu…
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II
A retrospective registry of patients with acute heparin-induced thrombocytopenia type II (HIT II) was completed, with results posted in 2011…
-
CLINICAL_TRIALS trial_result · 2010-03-09Clinical Trial Update: Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)
The HOT study evaluated the presence of blood clots in people with heparin-induced thrombocytopenia. The trial was terminated and results we…
-
CLINICAL_TRIALS trial_result · 2009-03-02Clinical Trial Update: Heparin Induced Thrombocytopenia: Pharmacoeconomics
This completed clinical trial update reports on the pharmacoeconomic analysis and cost implications of managing heparin-induced thrombocytop…
-
CLINICAL_TRIALS trial_result · 2008-11-13Clinical Trial Update: Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Argatroban for treating heparin-induced thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-18Clinical Trial Update: Heparin-Induced Thrombocytopenia Registry
The Heparin-Induced Thrombocytopenia Registry sponsored by Brigham and Women's Hospital has completed. It collects and reports outcomes in p…
-
CLINICAL_TRIALS trial_result · 2007-12-06Clinical Trial Update: Heparin Antibodies in Intensive Care Unit Patients (HAICU)
The HAICU trial update indicates that the study evaluating heparin antibodies in ICU patients with heparin-induced thrombocytopenia has comp…